Literature DB >> 2420922

Murine cytotoxic T cells specific to respiratory syncytial virus recognize different antigenic subtypes of the virus.

C R Bangham, B A Askonas.   

Abstract

The aim of this study was to establish whether cytotoxic T cells (Tc), raised against respiratory syncytial virus (RSV) in the mouse, are specific to the strain of immunizing virus, or cross-reactive between virus strains. Several recent studies using monoclonal antibodies have begun to define the antigenic variation among strains of RSV. It is likely that a successful RSV vaccine will need to contain antigenic determinants from more than one subtype, but since only the highest levels of neutralizing antibody are able to give complete protection against RSV infection, a vaccine may also need to elicit a cellular immune response. We have recently described H-2-restricted, RSV-specific Tc following RSV infection in the mouse; we present here evidence that polyclonal RSV-specific Tc in the mouse recognize syngeneic target cells infected with every human strain of RSV tested, whatever the subtype. The only RSV strain that appeared not to be recognized was bovine RSV, which seems unable to infect mouse cells; however, bovine cells, infected with bovine RSV and fixed with glutaraldehyde, primed mice for Tc which recognized human strains of RSV.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2420922     DOI: 10.1099/0022-1317-67-4-623

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  10 in total

1.  Specific human cytotoxic T cells recognize B-cell lines persistently infected with respiratory syncytial virus.

Authors:  C R Bangham; A J McMichael
Journal:  Proc Natl Acad Sci U S A       Date:  1986-12       Impact factor: 11.205

Review 2.  Immunity to human and bovine respiratory syncytial virus.

Authors:  T G Kimman; F Westenbrink
Journal:  Arch Virol       Date:  1990       Impact factor: 2.574

3.  The 22,000-kilodalton protein of respiratory syncytial virus is a major target for Kd-restricted cytotoxic T lymphocytes from mice primed by infection.

Authors:  P J Openshaw; K Anderson; G W Wertz; B A Askonas
Journal:  J Virol       Date:  1990-04       Impact factor: 5.103

4.  Cytolytic T-lymphocyte responses to respiratory syncytial virus: effector cell phenotype and target proteins.

Authors:  J A Nicholas; K L Rubino; M E Levely; E G Adams; P L Collins
Journal:  J Virol       Date:  1990-09       Impact factor: 5.103

Review 5.  Immunopathological mechanisms in respiratory syncytial virus disease.

Authors:  P J Openshaw
Journal:  Springer Semin Immunopathol       Date:  1995

Review 6.  Respiratory syncytial virus infection: immune response, immunopathogenesis, and treatment.

Authors:  J B Domachowske; H F Rosenberg
Journal:  Clin Microbiol Rev       Date:  1999-04       Impact factor: 26.132

Review 7.  Respiratory syncytial virus: virology, diagnosis, and vaccination.

Authors:  G L Toms
Journal:  Lung       Date:  1990       Impact factor: 2.584

8.  Noninfectious rotavirus (strain RRV) induces an immune response in mice which protects against rotavirus challenge.

Authors:  P A Offit; K I Dudzik
Journal:  J Clin Microbiol       Date:  1989-05       Impact factor: 5.948

9.  Recognition of bovine respiratory syncytial virus proteins by bovine CD8+ T lymphocytes.

Authors:  Ruth M Gaddum; Roy S Cook; Julie M Furze; Shirley A Ellis; Geraldine Taylor
Journal:  Immunology       Date:  2003-02       Impact factor: 7.397

10.  Alum Adjuvant Enhances Protection against Respiratory Syncytial Virus but Exacerbates Pulmonary Inflammation by Modulating Multiple Innate and Adaptive Immune Cells.

Authors:  Ki-Hye Kim; Young-Tae Lee; Hye Suk Hwang; Young-Man Kwon; Yu-Jin Jung; Youri Lee; Jong Seok Lee; Yu-Na Lee; Soojin Park; Sang-Moo Kang
Journal:  PLoS One       Date:  2015-10-15       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.